Papers
6
Total Citations
89
H-Index
3
About
Dr. Junji Wang is a leading figure in the rapidly evolving field of robotic urologic surgery, with a focused expertise in comparative effectiveness research and surgical innovation. His major contributions center on rigorously evaluating next-generation robotic platforms against established systems. Dr. Wang’s seminal 2023 meta-analysis comparing robot-assisted to open radical prostatectomy, which has garnered 70 citations, provides foundational evidence for the superiority of minimally invasive approaches. He has since pioneered the assessment of emerging technologies, including the AirSeal insufflation system and the novel Hinotori surgical robot, through a series of systematic reviews. His 2024 and 2025 meta-analyses, which compare Hinotori with the da Vinci system in radical prostatectomy and broader urologic surgery, are among the first to quantify the performance of this new competitor, directly shaping clinical adoption decisions. Dr. Wang’s work also extends to evaluating advanced intraoperative techniques, such as indocyanine green during cystectomy, and single-port nephrectomy. By synthesizing high-level evidence with modest but growing citation impact, Dr. Wang is establishing himself as a critical evaluator of surgical technology, guiding the field toward safer, more effective, and more accessible robotic procedures.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6